Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/53152
Conference/Presentation Title: Assessment of hydroxocobalamin (Cyanokit) interference on coagulation tests performed on two different methods.
Authors: Sam K.M.;Liu S.;Morgan S.;Clifford J.;Schneider H.G.;Lam Q.T.
Monash Health Department(s): Pathology
Institution: (Sam, Schneider, Lam) Clinical Biochemistry Department, Alfred Pathology Service, Alfred Health, Melbourne, VIC, Australia
(Sam) School of Clinical Science, Monash University, Clayton, VIC, Australia
(Liu, Morgan) Laboratory Haematology Department, Alfred Pathology Service, Alfred Health, Melbourne, VIC, Australia
(Clifford) Laboratory Haematology Department, Monash Pathology, Monash Health, Clayton, VIC, Australia
(Schneider) Department of Epidemiology and Preventative Medicine, Monash University, Melbourne, VIC, Australia
Presentation/Conference Date: 24-Jan-2025
Copyright year: 2025
Publisher: Elsevier B.V.
Publication information: Pathology. Conference: Pathology Update 2025. Melbourne Convention and Exhibition Centre, Melbourne Australia. 57(Supplement 1) (pp S86-S87), 2025. Date of Publication: 01 Feb 2025.
Journal: Pathology
Abstract: Background: Hydroxocobalamin, the antidote of choice for cyanide toxicity, causes red dis-coloration of plasma reportedly interfering with laboratory tests.1,2 We report the findings from hydroxocobalamin spiking studies of plasma pools on two commonly used coagulation platforms. Method(s): Three patient-pools (PP) were prepared to test PT, INR, APTT, Fibrinogen, D-dimer and Anti-Xa concentrations. Each PP was spiked with 2 different hydroxocobalamin concentrations (high and low spike) and equal volume of coagulation buffers. The 15 samples (5 samples per PP) were tested using Stago STA-R Max (clot-based) and ACL Top750 (spectrophotometric) analysers. Result(s): The buffer pools did not show significant dilution effect on both platforms. When spiked plasma pools results were assessed against the RCPAQAP APS (Analytical Performance Specifications), both methods showed mild degree of interference on PT (28% Stago, 22% ACL-Top) and INR (29% Stago, 22% ACL-Top). The rest of haemostasis parameters were acceptable on both platforms as per APS. Discussion(s): Our study showed unexpected result of the clot-based method marginally more susceptible to hydroxocobalamin interference than the spectrophotometric method, which warrants further research to identify the interfering mechanism. Interval testing or checking on a different method is recommended in case of hydroxocobalamin interference where laboratory results are not clinically fitting.Copyright © 2024
Conference Name: PATHOLOGY UPDATE 2025
Conference Start Date: 2025-02-21
Conference End Date: 2025-02-23
Conference Location: Melbourne Convention and Exhibition Centre, Melbourne, Australia
DOI: http://monash.idm.oclc.org/login?url=http://acs.hcn.com.au/?acc=36265&url=https://dx.doi.org/10.1016/j.pathol.2024.12.356
URI: https://repository.monashhealth.org/monashhealthjspui/handle/1/53152
Type: Conference Abstract
Subjects: blood clotting
hemostasis
spectrophotometry
thromboelastograph
Appears in Collections:Conferences

Show full item record

Page view(s)

16
checked on Feb 21, 2025

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.